Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Martha L Arellano"'
Autor:
Daniel J DeAngelo, Yi Lin, Roch Houot, Marion Subklewe, Petra C Schuberth, Michael R Bishop, Nicolas Boissel, Dimitrios Tzachanis, Jae H Park, Monique C Minnema, Thibaut Leguay, Mehrdad Abedi, Bijal D Shah, Ryan D Cassaday, Olalekan O Oluwole, Aaron C Logan, Max S Topp, Kristen M O'Dwyer, Martha L Arellano, Maria R Baer, Gary J Schiller, William G Wierda, Patrick J Stiff, Deepa Jeyakumar, Daqin Mao, Sabina Adhikary, Lang Zhou, Rita Damico Khalid, Armin Ghobadia
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 8 (2023)
Background Brexucabtagene autoleucel (brexu-cel) is an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy approved in the USA for adults with relapsed or refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL) and in the Europea
Externí odkaz:
https://doaj.org/article/6d2eb34905f7419ca7f3a7451cc9953e
Autor:
Claire Roddie, Karamjeet Sandhu, Eleni Tholouli, Paul Shaughnessy, Pere Barba Suñol, Manuel Nuno Direito de Morais Guerreiro, Mehrdad Abedi, Michael Bishop, Jean Yared, Armin Ghobadi, Deborah Yallop, Aaron Logan, Beitinjaneh Amer, Jeremy Pantin, Martha L Arellano, Sridhar Chaganti, Ram Malladi, Tobias Menne, Virginia Escamilla, Katharine Hodby, Krishna Gundabolu, Luke Mountjoy, Kristen Odwyer, Sameem Abedin, Hassan Alkhateeb, Bijal Shah, Silvia Basilico, Deborah Cluxton, Joanna Dawes, Pierre Lao-Sirieix, Meera Raymond, Justin Shang, Yanqing Hu, Gianfranco Pittari, Kapil Saxena, Wolfram Brugger, Y Zhang, Martin Pule, Daniel Park, Daniel De Angelo, Elias Jabbour
Publikováno v:
HemaSphere, Vol 7, p e998506d (2023)
Externí odkaz:
https://doaj.org/article/847828f94a674a0c9263a5a47141ff67
Autor:
Keith Pratz, Courtney Dinardo, Martha L Arellano, Michael Thirman, Vinod Pullarkat, Pamela S. Becker, B. Douglas Smith, Meng Zhang, Michael E Werner, Jalaja Potluri, Daniel A. Pollyea
Publikováno v:
HemaSphere, Vol 7, p e68978fe (2023)
Externí odkaz:
https://doaj.org/article/9d932cfaecc64a378a4df2ef7714d55c
Autor:
Courtney Dinardo, Gail Roboz, Justin M. Watts, Yazan Madanat, Gabrielle T Prince, Praneeth Baratam, Stéphane de Botton, Anthony Stein, James M Foran, Martha L Arellano, David Sallman, Dylan M Marchione, Xiaofei Bai, Prapti A Patel, Stephanie M Kapsalis, Guillermo Garcia-Manero, Amir Fathi
Publikováno v:
HemaSphere, Vol 7, p e75740ab (2023)
Externí odkaz:
https://doaj.org/article/ef75106ce8e24f1e977196cb95926e51
Autor:
Bijal D. Shah, Armin Ghobadi, Olalekan O. Oluwole, Aaron C. Logan, Nicolas Boissel, Ryan D. Cassaday, Thibaut Leguay, Michael R. Bishop, Max S. Topp, Dimitrios Tzachanis, Kristen M. O’Dwyer, Martha L. Arellano, Yi Lin, Maria R. Baer, Gary J. Schiller, Jae H. Park, Marion Subklewe, Mehrdad Abedi, Monique C. Minnema, William G. Wierda, Daniel J. DeAngelo, Patrick Stiff, Deepa Jeyakumar, Jinghui Dong, Sabina Adhikary, Lang Zhou, Petra C. Schuberth, Imi Faghmous, Behzad Kharabi Masouleh, Roch Houot
Publikováno v:
Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-11 (2022)
Abstract Background Brexucabtagene autoleucel (KTE-X19) is an autologous anti-CD19 CAR T-cell therapy approved in the USA to treat adult patients with relapsed or refractory B-precursor acute lymphoblastic leukemia (R/R B-ALL) based on ZUMA-3 study r
Externí odkaz:
https://doaj.org/article/c6f5581c75904c159d9b64a730068459
Autor:
Antoine N. Saliba, Scott H. Kaufmann, Eytan M. Stein, Prapti A. Patel, Maria R. Baer, Wendy Stock, Michael Deininger, William Blum, Gary J. Schiller, Rebecca L. Olin, Mark R. Litzow, Tara L. Lin, Brian J. Ball, Michael M. Boyiadzis, Elie Traer, Olatoyosi Odenike, Martha L. Arellano, Alison Walker, Vu H. Duong, Tibor Kovacsovics, Robert H. Collins, Abigail B. Shoben, Nyla A. Heerema, Matthew C. Foster, Kevin L. Peterson, Paula A. Schneider, Molly Martycz, Theophilus J. Gana, Leonard Rosenberg, Sonja Marcus, Ashley O. Yocum, Timothy Chen, Mona Stefanos, Alice S. Mims, Uma Borate, Amy Burd, Brian J. Druker, Ross L. Levine, John C. Byrd, James M. Foran
Publikováno v:
Blood Advances. 7:2360-2363
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::492444b38fef8304f0e0d1fa33a7f531
https://doi.org/10.1182/bloodadvances.2022008625
https://doi.org/10.1182/bloodadvances.2022008625
Autor:
Martha L. Arellano, Anand P. Jillella, Leonard T. Heffner, Manila Gaddh, Amelia A. Langston, Hanna J. Khoury, Abhishek Mangaonkar, Vamsi K. Kota
Publikováno v:
Hematology Reports, Vol 11, Iss 4 (2019)
Not available.
Externí odkaz:
https://doaj.org/article/8174d28dbbf0474ab27003879ac3cd01
Autor:
Uma Borate, Rui Li, Ying Huang, Ronan T. Swords, Elie Traer, Eytan Stein, James M. Foran, Maria R. Baer, Vu H. Duong, Wendy Stock, Olatoyosi Odenike, Prapti Patel, Robert H. Collins, Yazan F. Madanat, Tibor Kovacsovics, Michael W. Deininger, Catherine Smith, Rebecca L. Olin, Martha L. Arellano, William G. Blum, Gary J. Schiller, Tara L. Lin, Matthew C. Foster, Michael M. Boyiadzis, Robert L. Redner, Zeina Al-Mansour, Emily K Curran, Nyla A. Heerema, Theophilus J Gana, Molly Martycz, Leonard Rosenberg, Sonja Marcus, Ashley O. Yocum, Timothy Chen, Mona Stefanos, Franchesca Druggan, Amy Burd, Ross L. Levine, Brian J. Druker, John C. Byrd, Alice S. Mims
Publikováno v:
Blood. 140:6200-6203
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c85818d272ceb615c08abdf5d7bdd8a6
https://doi.org/10.1182/blood-2022-167316
https://doi.org/10.1182/blood-2022-167316
Autor:
Vu H. Duong, Amy S. Ruppert, Alice S. Mims, Uma Borate, Eytan M. Stein, Maria R. Baer, Wendy Stock, Tibor Kovacsovics, William Blum, Martha L. Arellano, Gary J. Schiller, Rebecca L. Olin, James M. Foran, Mark R. Litzow, Tara L. Lin, Prapti A. Patel, Matthew C. Foster, Robert L. Redner, Zeina Al‐Mansour, Christopher R. Cogle, Ronan T. Swords, Robert H. Collins, Jo‐Anne Vergilio, Nyla A. Heerema, Leonard Rosenberg, Ashley O. Yocum, Sonja Marcus, Timothy Chen, Franchesca Druggan, Mona Stefanos, Theophilus J. Gana, Abigail B. Shoben, Brian J. Druker, Amy Burd, John C. Byrd, Ross L. Levine, Michael M. Boyiadzis
Publikováno v:
Cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::706f268b5dd9aff5628a54000d561f77
https://doi.org/10.1002/cncr.34780
https://doi.org/10.1002/cncr.34780
Autor:
Hagop M. Kantarjian, Catherine L. Miller, Jalaja Potluri, Brenda Chyla, Yinghui Duan, Monique Dail, Roberto M. Lemoli, Atsushi Shinagawa, B. Douglas Smith, David A. Rizzieri, Marina Konopleva, Walter Fiedler, Arnaud Pigneux, Martha L. Arellano, Courtney D. DiNardo, Daniel A. Pollyea
Purpose:To evaluate efficacy and safety of venetoclax + azacitidine among treatment-naïve patients with IDH1/2-mutant (mut) acute myeloid leukemia (AML).Patients and Methods:Data were pooled from patients enrolled in a phase III study (NCT02993523)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25065976dfc434e19afcc1a8433e5bbf
https://doi.org/10.1158/1078-0432.c.6532287.v1
https://doi.org/10.1158/1078-0432.c.6532287.v1
